{
    "organizations": [],
    "uuid": "45606b67bd73dddaf7af48009eb4195bb6d9a4e6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-intercept-announces-updated-us-pre/brief-intercept-announces-updated-u-s-prescribing-information-for-ocaliva-idUSFWN1PR0X0",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Announces Updated U.S. Prescribing Information For Ocaliva",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 1, 2018 / 3:10 PM / in 11 minutes BRIEF-Intercept Announces Updated U.S. Prescribing Information For Ocaliva Reuters Staff 2 Min Read \nFeb 1 (Reuters) - Intercept Pharmaceuticals Inc: \n* INTERCEPT ANNOUNCES UPDATED U.S. PRESCRIBING INFORMATION FOR OCALIVA® (OBETICHOLIC ACID) TO REINFORCE APPROPRIATE DOSING IN PBC PATIENTS WITH ADVANCED CIRRHOSIS \n* INTERCEPT PHARMACEUTICALS INC - OCALIVA LABEL HAS BEEN REVISED TO INCLUDE A BOXED WARNING \n* INTERCEPT PHARMACEUTICALS INC - INTERCEPT WILL BE DISSEMINATING UPDATED PRESCRIBING INFORMATION AND A MEDICATION GUIDE FOR PATIENTS \n* INTERCEPT PHARMACEUTICALS INC - OCALIVA LABEL HAS BEEN REVISED TO INCLUDE A DOSING TABLE THAT REINFORCE EXISTING DOSING SCHEDULE FOR CERTAIN PATIENTS \n* INTERCEPT PHARMACEUTICALS INC - U.S. FOOD AND DRUG ADMINISTRATION HAS ISSUED AN UPDATED DRUG SAFETY COMMUNICATION TO ACCOMPANY LABEL \n* INTERCEPT PHARMACEUTICALS INC - UPDATED LABEL REINFORCES POSITIVE BENEFIT-RISK PROFILE OF OCALIVA WHEN USED AS DIRECTED \n* INTERCEPT PHARMACEUTICALS - TABLE IS INCLUDED IN UPDATED PRESCRIBING INFORMATION TO INCREASE PROMINENCE OF RECOMMENDED OCALIVA DOSAGE BY DISEASE STAGE \n* INTERCEPT PHARMA - TABLE INCLUDED UPDATED PRESCRIBING INFORMATION TO INCREASE PROMINENCE OF RECOMMENDED OCALIVA DOSAGE BY CHILD-PUGH CLASSIFICATION \n* INTERCEPT PHARMACEUTICALS - ALSO WORKING WITH EMA TO UPDATE OCALIVA EUROPEAN SMPC TO REINFORCE APPROPRIATE DOSING IN PATIENTS WITH ADVANCED CIRRHOSIS \n* INTERCEPT - CO‘S RECENT ASSESSMENT OF POSTMARKETING DATA DID NOT ESTABLISH CAUSAL RELATIONSHIP BETWEEN OCALIVA&LIVER DECOMPENSATION &/LIVER FAILURE Source text for Eikon: Further company coverage:",
    "published": "2018-02-01T17:09:00.000+02:00",
    "crawled": "2018-02-01T17:33:59.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "announces",
        "updated",
        "prescribing",
        "information",
        "ocaliva",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "intercept",
        "pharmaceutical",
        "inc",
        "intercept",
        "announces",
        "updated",
        "prescribing",
        "information",
        "obeticholic",
        "acid",
        "reinforce",
        "appropriate",
        "dosing",
        "pbc",
        "patient",
        "advanced",
        "cirrhosis",
        "intercept",
        "pharmaceutical",
        "inc",
        "ocaliva",
        "label",
        "revised",
        "include",
        "boxed",
        "warning",
        "intercept",
        "pharmaceutical",
        "inc",
        "intercept",
        "disseminating",
        "updated",
        "prescribing",
        "information",
        "medication",
        "guide",
        "patient",
        "intercept",
        "pharmaceutical",
        "inc",
        "ocaliva",
        "label",
        "revised",
        "include",
        "dosing",
        "table",
        "reinforce",
        "existing",
        "dosing",
        "schedule",
        "certain",
        "patient",
        "intercept",
        "pharmaceutical",
        "inc",
        "food",
        "drug",
        "administration",
        "issued",
        "updated",
        "drug",
        "safety",
        "communication",
        "accompany",
        "label",
        "intercept",
        "pharmaceutical",
        "inc",
        "updated",
        "label",
        "reinforces",
        "positive",
        "profile",
        "ocaliva",
        "used",
        "directed",
        "intercept",
        "pharmaceutical",
        "table",
        "included",
        "updated",
        "prescribing",
        "information",
        "increase",
        "prominence",
        "recommended",
        "ocaliva",
        "dosage",
        "disease",
        "stage",
        "intercept",
        "pharma",
        "table",
        "included",
        "updated",
        "prescribing",
        "information",
        "increase",
        "prominence",
        "recommended",
        "ocaliva",
        "dosage",
        "classification",
        "intercept",
        "pharmaceutical",
        "also",
        "working",
        "ema",
        "update",
        "ocaliva",
        "european",
        "smpc",
        "reinforce",
        "appropriate",
        "dosing",
        "patient",
        "advanced",
        "cirrhosis",
        "intercept",
        "co",
        "recent",
        "assessment",
        "postmarketing",
        "data",
        "establish",
        "causal",
        "relationship",
        "ocaliva",
        "liver",
        "decompensation",
        "failure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}